National Cancer Institute

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder	Active, not recruiting	Phase 3	2026-09-30		NCT05611931
Stress-reducing Intervention in Urothelial Carcinoma	Dyssomnias, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Inflammation, Male Urogenital Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sleep Disorders, Intrinsic, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, insomnia, neoplasm, nervous system disorder, psychiatric disorder, sleep-wake disorder, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder	Recruiting	Not applicable	2024-02-21		NCT06269536

Clinical trials